Nachrichten zur Taro Pharmaceuticals Industries Ltd. Aktie

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

PARSIPPANY, N.J. and CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva…

TEVA Pharmaceutical Aktie: Positive RELIEVE-UCCD-Daten - BofA sieht 1 Mrd. USD mehr Potenzial

Charlotte (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von BofA Securities:Die Analysten von BofA Securities stufen die Aktie von TEVA Pharmaceutical Industries Ltd.…

TEVA Pharmaceutical Aktie: Jetzt wird’s spannend! Goldman Sachs erhöht Kursziel

Bad Marienberg (www.aktiencheck.de) - TEVA Pharmaceutical: Goldman Sachs erhöht Kursziel und bleibt bei Rating "buy"Aktienanalyse mit frischem Rückenwind: Goldman Sachs…

Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’

PARSIPPANY, N.J., and TEL AVIV, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of…

Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

NEW YORK and PARSIPPANY, N.J., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Teva…

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

PARSIPPANY, N.J., and NEW YORK, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva…

TEVA Pharmaceutical Aktie: Kursziel 40 USD, neue Chancen durch innovative Biopharma-Pipeline

Minneapolis (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Piper Sandler:Die Analysten von Piper Sandler haben das Kursziel für TEVA Pharmaceutical Industries Ltd.…

TEVA Pharmaceutical Aktie: Kursziel steigt dank starker Austedo-Daten und stabiler Guidance

New York (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Goldman Sachs:Matt Dellatorre, Analyst von Goldman Sachs, stuft die Aktie von TEVA Pharmaceutical…

Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

PARSIPPANY, N.J., and TEL AVIV, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of…

Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?

Here is how Teva Pharmaceutical Industries Ltd. (TEVA) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector…

TEVA Pharmaceutical Aktie: Stabile Q3-Aussichten

Charlotte (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von BofA Securities:Bank of America (BofA) habe das Kursziel für die Aktie von TEVA Pharmaceutical…

Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

PARSIPPANY, N.J. and TEL AVIV, Israel, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate…

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

PARSIPPANY, N.J., and TEL AVIV, Israel, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of…

TEVA Pharmaceutical Aktie: Nach wie vor ein sicherer Hafen? Kurszielsenkung vor Zahlen

Minneapolis (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Piper Sandler: Piper Sandler habe in einer aktuellen Studie das Kursziel für die Aktie von…

TEVA Pharmaceutical Aktie: Unfairer Absturz - Jetzt die große Biotech-Chance?

Zürich (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse der UBS: Die Aktie von TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098, WKN: 883035, Ticker-Symbol: TEV, NYSE-Symbol:…

Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine

TEL AVIV, Israel, June 23, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…

TEVA Pharmaceutical Aktie: Kommt jetzt die Kurs-Explosion? JPMorgan sieht massives Aufwärtspotenzial!

New York (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von J.P. Morgan Securities: Laut einer aktuellen Einschätzung von JPMorgan könnte sich bei der Aktie…

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

PARSIPPANY, N.J. and TEL AVIV, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of…

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes

TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”)…

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031

TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”)…

TEVA Pharmaceutical Aktie: Kostenreduktion stärkt Gewinnprognosen bis 2027 - Kursziel gesteigert!

Charlotte (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von BofA Securities: Aktuelle Bewertung Bank of America (BofA) hat das Kursziel für TEVA Pharmaceutical Industries Ltd.…

Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

TEVA Pharmaceutical Aktie: Zölle und Patentklippen belasten Ausblick

London (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von HSBC: Rating und Kursziel HSBC hat das Kursziel für die Aktien von TEVA Pharmaceutical Industries Ltd.…

Teva Releases Q1 2025 Aide Memoire

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced…

TEVA Pharmaceutical Aktie: Gedämpfte EBITDA-Prognose belastet kurzfristig

London (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Barclays: Rating und Kursziel Barclays habe das Kursziel für TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098, WKN:…

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company…

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company…

TEVA Pharmaceutical Aktie: Stärkung des Markenportfolios im Bereich Neuropsychiatrie

Minneapolis (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Piper Sandler: 1. Kontext und Hintergrund Piper Sandler hat das Kursziel für die Aktie von TEVA…

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

TEL AVIV, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

TEL AVIV, Israel, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced…

TEVA Pharmaceutical Aktie: Fokus auf Schuldenabbau und strategische Neuausrichtung

Zürich (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse der UBS: Die UBS-Analystin Ashwani Verma hat das Kursziel für die Aktie von TEVA Pharmaceutical Industries…

TEVA Pharmaceutical Aktie: Studienresultate sorgen für gute Stimmung an der Börse

Kulmbach (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse vom Online-Anlegermagazin "Der Aktionär": Michel Doepke von "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

TEL AVIV, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)…

Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference

TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…

TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, Nov. 10, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally…

Teva to Present at the Jefferies London Healthcare Conference

TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…

TEVA Pharmaceutical: Kursziel erhöht

London (www.aktiencheck.de) - Rating-Update: Die Analysten von Barclays bestätigen die Empfehlung für die Aktie von TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098,…

TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally…

Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate

TEL AVIV, ISRAEL and MADRID, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a subsidiary of…

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia

TEL AVIV, Israel & PARSIPPANY, N.J., Sept. 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of…

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)

TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of…

dpa-AFX ProFeed